These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 17875341

  • 1. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
    Derin D, Soydinç HO, Guney N, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E.
    Lung Cancer; 2008 Feb; 59(2):240-5. PubMed ID: 17875341
    [Abstract] [Full Text] [Related]

  • 2. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A, Cafferata MA, Paganuzzi M, Filiberti R, Marroni P, Neri M, Fontana V, Nicoló G, Perdelli L, Stampino CG, Rosso R, Puntoni R.
    Cancer; 2001 Oct 01; 92(7):1896-904. PubMed ID: 11745263
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V, Spreafico A, Floriani I, Colombo B, Ludovini V, Pistola L, Bellezza G, Viganò MG, Villa E, Corti A.
    Cancer; 2007 Aug 15; 110(4):845-53. PubMed ID: 17599769
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P, Li J, Ge LP, Dai CH, Li XQ.
    Respirology; 2010 Apr 15; 15(3):501-9. PubMed ID: 20210890
    [Abstract] [Full Text] [Related]

  • 5. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E.
    Cancer Invest; 2006 Oct 15; 24(6):576-80. PubMed ID: 16982461
    [Abstract] [Full Text] [Related]

  • 6. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
    Dalaveris E, Kerenidi T, Katsabeki-Katsafli A, Kiropoulos T, Tanou K, Gourgoulianis KI, Kostikas K.
    Lung Cancer; 2009 May 15; 64(2):219-25. PubMed ID: 18845357
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E, Visca P, Novelli F, Casini B, Diodoro MG, Perrone-Donnorso R, Botti C, Sperduti I, Facciolo F, Milella M, Cecere FL, Cognetti F, Mottolese M.
    Eur J Surg Oncol; 2008 May 15; 34(5):593-8. PubMed ID: 17693049
    [Abstract] [Full Text] [Related]

  • 9. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA, Brooks KR, Joshi MB, Conlon D, Herndon J, Petersen RP, Harpole DH.
    Ann Thorac Surg; 2006 Jun 15; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients.
    De Vita F, Orditura M, Auriemma A, Infusino S, Catalano G.
    J Exp Clin Cancer Res; 1998 Dec 15; 17(4):413-7. PubMed ID: 10089060
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy.
    Naumnik W, Chyczewska E, Ossolinska M.
    Cancer Invest; 2009 Aug 15; 27(7):741-6. PubMed ID: 19340656
    [Abstract] [Full Text] [Related]

  • 14. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
    Warnecke-Eberz U, Baldus SE, Bollschweiler E, Hoelscher AH, Metzger R.
    Anticancer Res; 2008 Aug 15; 28(3A):1525-9. PubMed ID: 18630507
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer.
    De Vita F, Orditura M, Auriemma A, Infusino S, Roscigno A, Catalano G.
    Oncol Rep; 1998 Aug 15; 5(3):649-52. PubMed ID: 9538169
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.